|Articles|May 5, 2017
SGS Announces Results of H3N2 Influenza Trial
SGS announced the successful completion of a Phase I clinical trial of a new strain of influenza virus in healthy volunteers.
Advertisement
SGS announced the successful completion of a Phase I clinical trial of a new strain of influenza virus in healthy volunteers. The agent is approved for use as a challenge agent in studies demonstrating the early efficacy of influenza drugs and vaccines.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
3
ACT Brief: Substance Versus Branding in Biotech Support, Site-Level Execution Gaps and Point-of-Care Data, and KCNT1-Targeted Pediatric Epilepsy Program
4
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
5